Regencell Bioscience Holdings Limited (RGC) market cap

Market cap today
$2.26B

Regencell Bioscience Holdings Limited (RGC) has a market cap of $2.26B. At the end of fiscal 2026 (June 30, 2026) its market cap was $3.02B. Today's figure is 25.3% below the fiscal 2026 year-end. Figures as of 18 Nov 2026, 10:34 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Market cap today
$2.26B
Market cap, fiscal 2026
$3.02B
Highest on record
$3.02Bfiscal 2026
Lowest on record
$43.72Mfiscal 2024
Fiscal years on record
42022–2026

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Regencell Bioscience Holdings Limited market cap, in more detail

Across the 4 fiscal year-ends on record (2022–2026), the highest was $3.02B in fiscal 2026 and the lowest $43.72M in fiscal 2024.

History · 4 fiscal years

Market cap at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Regencell Bioscience Holdings Limited market cap, year by year

Regencell Bioscience Holdings Limited (RGC) market cap by fiscal year
Fiscal yearMarket capChangeYear endedShare price at year-endDiluted shares
Today$2.26B—$4.55—
2026$3.02B—$6.09495.88M
2024$43.72M 85.4% down$0.09494.49M
2023$299.82M 32.3% down$0.61494.49M
2022$443.14M—$0.91486.62M
2021———380.00M
2020———380.00M
2019———2

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

How to read it

It is what the stock market says the whole company is worth — a measure of size, not of whether the shares are cheap or dear.

More on RGC

Regencell Bioscience Holdings Limited, figure by figure

Regencell Bioscience Holdings Limited (RGC) overview: price, valuation and scorecard

Regencell Bioscience Holdings Limited market cap: questions and answers

What is Regencell Bioscience Holdings Limited's market cap?

Regencell Bioscience Holdings Limited (RGC) has a market cap of $2.26B. At the end of fiscal 2026 (June 30, 2026) its market cap was $3.02B.

What are the highest and lowest market cap figures on record for Regencell Bioscience Holdings Limited?

Across the 4 fiscal year-ends on record (2022–2026), the highest was $3.02B in fiscal 2026 and the lowest $43.72M in fiscal 2024.

How is Regencell Bioscience Holdings Limited's market cap calculated?

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote. For Regencell Bioscience Holdings Limited it is on record here for 4 fiscal years, 2022 to 2026.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Regencell Bioscience Holdings Limited (RGC) market cap”, data as of 18 November 2026. https://funkfolio.com/stock/RGC/market-cap

Underlying data: the company's filings with the SEC and Yahoo Finance.